Virtu Financial’s InMed Pharmaceuticals INM Stock Holding History

Virtu Financial’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13K	Buy	+19,980	New	+$18.8K	﹤0.01%	1440
2025 Q4	–	Sell	-20,369	Closed	-$45K	–	1928
2025 Q3	$45K	Buy	+20,369	New	+$49.1K	﹤0.01%	1148
2024 Q4	–	Sell	-1,421	Closed	-$7K	–	1775
2024 Q3	$7K	Sell	1,421 -2,913	-67%	-$14.8K	﹤0.01%	1232
2024 Q2	$23K	Buy	+4,334	New	+$24.8K	﹤0.01%	1014
2023 Q1	–	Sell	-886	Closed	-$36K	–	1772
2022 Q4	$36K	Buy	+886	New	+$59.6K	﹤0.01%	1144
2021 Q4	–	Sell	-23	Closed	-$20K	–	1928
2021 Q3	$20K	Buy	+23	New	+$27.4K	﹤0.01%	1382

Other funds holding INM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PWMG

Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Virtu Financial's INM Position: Q1 2026 in Review

Virtu Financial opened a new position in InMed Pharmaceuticals (INM) in Q1 2026: 19,980 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #1440 among its holdings. This is a return to the name: Virtu Financial previously reported a position in INM as recently as Q3 2025.

Virtu Financial first reported a position in INM in Q3 2021 and has held it in 6 quarters since. The position peaked at $45K in Q3 2025. 9 funds tracked by Wall St. Rank hold INM as of Q1 2026.

Virtu Financial held 19,980 shares of InMed Pharmaceuticals worth $13K as of Q1 2026.
InMed Pharmaceuticals was a new Virtu Financial position in Q1 2026.
InMed Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1440 holding.
Virtu Financial first reported a position in InMed Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
Virtu Financial's InMed Pharmaceuticals position peaked at $45K in Q3 2025.
9 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.